RAYTHEON CO's ticker is RTN and the CUSIP is 755111507. A total of 660 filers reported holding RAYTHEON CO in Q2 2013. The put-call ratio across all filers is 0.68 and the average weighting 0.3%.
About RAYTHEON CO
Raytheon Co. is a leading technology and innovation company that specializes in defense, civil government, and cybersecurity solutions. With a history spanning over 90 years, Raytheon has established itself as a trusted partner to governments and businesses around the world.
One of the key strengths of Raytheon is its focus on research and development. The company invests heavily in cutting-edge technologies and has a strong track record of delivering innovative solutions to its customers. This has helped Raytheon to stay ahead of the competition and maintain its position as a leader in the industry.
Another factor that sets Raytheon apart is its commitment to sustainability. The company has set ambitious goals to reduce its environmental impact and has implemented a number of initiatives to achieve these goals. This includes reducing greenhouse gas emissions, conserving water, and minimizing waste.
Despite the challenges posed by the COVID-19 pandemic, Raytheon has continued to perform well. The company reported strong financial results in the first quarter of 2021, with net sales of $15.2 billion and earnings per share of $0.90. This is a testament to the resilience of the company and its ability to adapt to changing market conditions.
Overall, Raytheon is a company that is well-positioned for long-term success. With its focus on innovation, sustainability, and strong financial performance, Raytheon is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $238,000 | +11.7% | 1,084 | 0.0% | 0.03% | +7.7% |
| Q3 2019 | $213,000 | -11.2% | 1,084 | -6.6% | 0.03% | -7.1% |
| Q3 2018 | $240,000 | +7.1% | 1,160 | 0.0% | 0.03% | +3.7% |
| Q2 2018 | $224,000 | -39.0% | 1,160 | -31.6% | 0.03% | -41.3% |
| Q1 2018 | $367,000 | +7.0% | 1,697 | -7.0% | 0.05% | +7.0% |
| Q4 2017 | $343,000 | -1.4% | 1,824 | -2.0% | 0.04% | -2.3% |
| Q3 2017 | $348,000 | +5.8% | 1,861 | -8.8% | 0.04% | +4.8% |
| Q2 2017 | $329,000 | +7.5% | 2,040 | +1.7% | 0.04% | +7.7% |
| Q1 2017 | $306,000 | +3.7% | 2,005 | -3.7% | 0.04% | -4.9% |
| Q4 2016 | $295,000 | -23.6% | 2,082 | -26.5% | 0.04% | -22.6% |
| Q3 2016 | $386,000 | +32.6% | 2,832 | +32.5% | 0.05% | +29.3% |
| Q2 2016 | $291,000 | +12.8% | 2,137 | +1.7% | 0.04% | +13.9% |
| Q1 2016 | $258,000 | -13.1% | 2,102 | -11.9% | 0.04% | -12.2% |
| Q4 2015 | $297,000 | +13.8% | 2,385 | -0.2% | 0.04% | -2.4% |
| Q3 2015 | $261,000 | -18.9% | 2,390 | -29.0% | 0.04% | -8.7% |
| Q2 2015 | $322,000 | -17.4% | 3,365 | -5.6% | 0.05% | -16.4% |
| Q1 2015 | $390,000 | +1.0% | 3,565 | 0.0% | 0.06% | -1.8% |
| Q4 2014 | $386,000 | +6.3% | 3,565 | -0.2% | 0.06% | -9.7% |
| Q3 2014 | $363,000 | -53.0% | 3,571 | -57.3% | 0.06% | -48.3% |
| Q2 2014 | $772,000 | -9.7% | 8,371 | -3.2% | 0.12% | -14.9% |
| Q1 2014 | $855,000 | 0.0% | 8,646 | -8.3% | 0.14% | +3.7% |
| Q4 2013 | $855,000 | -37.9% | 9,431 | -51.0% | 0.14% | +7.1% |
| Q3 2013 | $1,377,000 | +114.2% | 19,262 | +97.9% | 0.13% | +5.0% |
| Q2 2013 | $643,000 | – | 9,731 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brick & Kyle, Associates | 62,251 | $4,480 | 2.38% |
| Providence Wealth Advisors, LLC | 6,475 | $462,478 | 0.52% |
| PHYSICIANS FINANCIAL SERVICES, INC. | 14,579 | $1,049 | 0.43% |
| Shakespeare Wealth Management, LLC | 8,383 | $603,325 | 0.21% |